Proteomics Market Analysis

  • Report ID: 5361
  • Published Date: Sep 11, 2025
  • Report Format: PDF, PPT

Proteomics Market Segmentation:

Component Segment Analysis

The reagent segment in the proteomics market is predicted to gather the highest revenue share by the end of 2035. The growth of the segment can be attributed to the fact that reagents and consumables are in high demand due to the extensive use of kits, chemicals, strips, reagents & consumables, and other materials for the analysis of various biological samples in research labs, academic institutions, and other settings. High-quality chemical reagents are in high demand since proteomics research is complex and multidisciplinary. Mass spectrometry (MS)-based proteomics research has made use of novel chemical agents and methodologies. The goal of the synthesis of many chemical substances, including peptides and proteins, is to covalently bind them to biomolecules.

Application Segment Analysis

The reagent segment in the proteomics market is predicted to gather the highest revenue share by the end of 2035.  The drug discovery category is expected to grow at the fastest rate over the projected period. The growth of this market may be ascribed to the advancement of structure-based drug design, heightened focus on creating customized medications, and greater financial support for these initiatives. Proteomics technologies also offer a method to show early in a drug discovery programme, which helps the segment grow by saving pharmaceutical companies a lot of money and eventually helping patients and healthcare systems.

Our in-depth analysis of the global market includes the following segments:

                              Component

  • Instrument
  •  Reagents
  • Software & Services

                              Application 

  • Clinical Discovery
  • Drug Discovery
  • Others 

                              End-User

  • Hospitals
  • Clinical Laboratories
  • Bio-pharmaceutical Companies
  • Academic & Research Laboratories
  • Others 

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of proteomics is assessed at USD 39.77 Billion.

The global proteomics market size was valued at over USD 35.46 Billion in 2025 and is expected to register a CAGR of around 13.5%, exceeding USD 125.8 Billion revenue by 2035.

The North America proteomics market is expected to capture 43% share by 2035, driven by rising demand for protein therapies and antibody-drug conjugates.

Key players in the market include Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Merck KGaA, Agilent Technologies, Inc., Bruker Corporation, Luminex Corporation, QIAGEN N.V., PerkinElmer, Inc., Waters Corporation, Biognosys Technologies Pvt. Ltd., HORIBA, Ltd., Perseus Proteomics Inc., FIMECS, Inc., Olink Holding AB.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos